Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries" von Moes, Harmen R, Buskens, Erik, van Laar, Teus

Volltext

Correction: Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countr... von Moes, Harmen R, Buskens, Erik, van Laar, Teus

Volltext

Acute effects of adaptive Deep Brain Stimulation in Parkinson’s disease von Piña-Fuentes, Dan, van Dijk, J. Marc C., van Zijl, Jonathan C., Moes, Harmen R., van Laar, Teus, Oterdoom, D.L.Marinus, Little, Simon, Brown, Peter, Beudel, Martijn

Volltext

Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease von Moes, Harmen R, Buskens, Erik, van Laar, Teus

Volltext

Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review von Moes, Harmen R., Henriksen, Tove, Sławek, Jarosław, Phokaewvarangkul, Onanong, Buskens, Erik, van Laar, Teus

Volltext

Letter to the editor, “Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medic... von Moes, Harmen R., Buskens, Erik, van Laar, Teus

Volltext

Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool von Moes, Harmen R., ten Kate, Jolien M., Portman, Axel T., van Harten, Barbera, van Kesteren, Mirjam E., Mondria, Tjeerd, Lunter, Gerton, Buskens, Erik, van Laar, Teus

Volltext

Patient Referral for Device‐Aided Therapies in Parkinson's Disease is Suboptimal; A Dutch Survey von Moes, Harmen R., Kate, Jolien M., Buskens, Erik, Laar, Teus

Volltext